Psicose Epimerase and Psicose Production Method Using Same

US2017101637A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017101637-A1
Application numberUS-201515128812-A
CountryUS
Kind codeA1
Filing dateMay 22, 2015
Priority dateMay 28, 2014
Publication dateApr 13, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a novel psicose epimerase derived from Flavonifractor plautii and capable of converting fructose to psicose. The novel psicose epimerase according to the present invention possesses an activity producing psicose by epimerizing the carbon-3 position of fructose, and has maximal activity for the conversion of fructose to psicose at a relatively high temperature and a pH less than or equal to neutral, has excellent thermal stability, and can mass-produce psicose from fructose in a high yield for a short amount of time. Therefore, the psicose epimerase according to the present invention is advantageous in the industrial production of psicose, and it is expected that the psicose produced thereby can be usefully utilized in the functional sugar industry and also as materials for health food, medicine, cosmetics, and the like using the psicose.

First claim

Opening claim text (preview).

1 - 6 . (canceled) 7 . A composition for producing psicose, the composition comprising a psicose epimerase consisting of an amino acid sequence of SEQ ID NO: 1, a recombinant strain, a culture of the recombinant strain, or a lysate of the recombinant strain, wherein the recombinant strain is transformed by a polynucleotide coding the psicose epimerase consisting of the amino acid sequence of SEQ ID NO: 1 or a recombinant vector including the polynucleotide. 8 . The composition for producing psicose of claim 7 , wherein the psicose epimerase is derived from Flavonifractor plautii. 9 . The composition for producing psicose of claim 7 , wherein the polynucleotide consists of a base sequence of SEQ ID NO: 2. 10 . The composition for producing psicose of claim 7 , wherein the recombinant vector has a cleavage map of FIG. 1 . 11 . The composition for producing psicose of claim 7 , the composition further comprising: one or more kinds selected from the group consisting of manganese ions, nickel ions, and cobalt ions. 12 . A method for producing psicose, the method comprising: reacting fructose with a psicose epimerase consisting of an amino acid sequence of SEQ ID NO: 1, a recombinant strain, a culture of the recombinant strain, a lysate of the recombinant strain, or a composition including one or more thereof, wherein the recombinant strain is transformed by a polynucleotide coding the wherein the recombinant strain is transformed by a polynucleotide coding the recombinant vector including the polynucleotide. 13 . The method for producing psicose of claim 12 , wherein the psicose epimerase is derived from Flavonifractor plautii. 14 . The method for producing psicose of claim 12 , wherein the polynucleotide consists of a base sequence of SEQ ID NO: 2. 15 . The method for producing psicose of claim 12 , wherein the recombinant vector has a cleavage map of FIG. 1 . 16 . The method for producing psicose of claim 12 , wherein the composition further includes one or more kinds selected from the group consisting of manganese ions, nickel ions, and cobalt ions. 17 . The method for producing psicose of claim 12 , wherein a temperature of the reaction is 55 to 67° C. and a pH of the reaction is 6.5 to 8. 18 . The method for producing psicose of claim 12 , wherein the concentration of the fructose is 35 to 75% (w/w). 19 . The method for producing psicose of claim 12 , wherein the psicose epimerase or the recombinant strain is immobilized in a carrier. 20 . The method for producing psicose of claim 12 , wherein a host strain of the recombinant strain is a cytologically safe strain.

Assignees

Inventors

Classifications

  • C12N9/90Primary

    Isomerases (5.) · CPC title

  • produced by the action of an isomerase, e.g. fructose · CPC title

  • acting on carbohydrates and derivatives (5.1.3) · CPC title

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017101637A1 cover?
The present invention provides a novel psicose epimerase derived from Flavonifractor plautii and capable of converting fructose to psicose. The novel psicose epimerase according to the present invention possesses an activity producing psicose by epimerizing the carbon-3 position of fructose, and has maximal activity for the conversion of fructose to psicose at a relatively high temperature an…
Who is the assignee on this patent?
Daesang Corp
What technology area does this patent fall under?
Primary CPC classification C12N9/90. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).